These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7482078

  • 1. The introduction of surfactant replacement therapy into South Africa.
    Davies VA, Rothberg AD, Ballot DE.
    S Afr Med J; 1995 Jul; 85(7):637-40. PubMed ID: 7482078
    [Abstract] [Full Text] [Related]

  • 2. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
    Malathi I, Ng KC.
    Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
    [Abstract] [Full Text] [Related]

  • 3. The cost and effectiveness of surfactant replacement therapy at Johannesburg Hospital, November 1991-December 1992.
    Davies VA, Ballot DE, Rothberg AD.
    S Afr Med J; 1995 Jul; 85(7):646-9. PubMed ID: 7482081
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The selection of infants for surfactant replacement therapy under conditions of limited financial resources.
    Ballot DE, Rothberg AD, Davies VA.
    S Afr Med J; 1995 Jul; 85(7):640-3. PubMed ID: 7482079
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of surfactant replacement therapy in a developing country.
    al Umran K, Yaseen H.
    J Trop Pediatr; 1997 Jun; 43(3):167-9. PubMed ID: 9231638
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S, Raju TN, Bhat R, Maeta H, Vidyasagar D.
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

  • 19. Exogenous surfactant therapy in hyaline membrane disease.
    Gitlin JD, Parad R, Taeusch HW.
    Semin Perinatol; 1984 Oct; 8(4):272-82. PubMed ID: 6387924
    [Abstract] [Full Text] [Related]

  • 20. Ventilation-perfusion relationships in preterm infants after surfactant treatment.
    Bowen W, Martin CR, Krauss AN, Auld PA.
    Pediatr Pulmonol; 1994 Sep; 18(3):155-62. PubMed ID: 7800432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.